Citigroup’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$6 6417
2025
Q4
$6 Sell
1
-28
-97% -$173 ﹤0.01% 5853
2025
Q3
$198 Hold
29
﹤0.01% 5766
2025
Q2
$260 Sell
29
-6,981
-100% -$41.4K ﹤0.01% 5467
2025
Q1
$37.7K Sell
7,010
-784
-10% -$5.33K ﹤0.01% 4955
2024
Q4
$58.1K Buy
7,794
+476
+7% +$3.91K ﹤0.01% 5048
2024
Q3
$66.2K Buy
7,318
+5,068
+225% +$52.3K ﹤0.01% 4927
2024
Q2
$23.9K Sell
2,250
-14,909
-87% -$159K ﹤0.01% 4949
2024
Q1
$151K Buy
17,159
+4,449
+35% +$36.2K ﹤0.01% 4135
2023
Q4
$86.7K Buy
12,710
+5,104
+67% +$41.9K ﹤0.01% 4255
2023
Q3
$74.2K Buy
+7,606
New +$60.9K ﹤0.01% 4022
2021
Q2
Sell
-603
Closed -$5K 6412
2021
Q1
$5K Sell
603
-918
-60% -$6.51K ﹤0.01% 5911
2020
Q4
$10K Buy
1,521
+1,084
+248% +$6.84K ﹤0.01% 6962
2020
Q3
$3K Sell
437
-609
-58% -$4K ﹤0.01% 7236
2020
Q2
$7K Sell
1,046
-278
-21% -$2.03K ﹤0.01% 7188
2020
Q1
$7K Buy
+1,324
New +$9.05K ﹤0.01% 7188
2019
Q2
Sell
-14,630
Closed -$150K 7864
2019
Q1
$150K Buy
+14,630
New +$131K ﹤0.01% 5370
2016
Q1
Sell
-77
Closed 7778
2015
Q4
$0 Buy
+77
New +$508 ﹤0.01% 7872
2015
Q1
Sell
-400
Closed -$1K 7440
2014
Q4
$1K Buy
+400
New +$1.23K ﹤0.01% 6998

Other funds holding ULBI

Citigroup's ULBI Position: Q1 2026 in Review

Citigroup sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 1 share — an estimated $6 sold.

Citigroup first reported a position in ULBI in Q4 2014 and held it in 18 quarters. The position peaked at $151K in Q1 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Citigroup reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 Ultralife share in Q1 2026, an estimated $6.
  • Citigroup first reported a position in Ultralife in Q4 2014 and held it in 18 quarters.
  • Citigroup's Ultralife position peaked at $151K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.